Patents by Inventor Michal Maragalith

Michal Maragalith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8852611
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Patent number: 8852610
    Abstract: This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: October 7, 2014
    Assignees: Vical Incorporated, The University of Washington
    Inventors: Adrian Vilalta, Michal Maragalith, Lichun Dong, David M. Koelle
  • Publication number: 20120328658
    Abstract: This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.
    Type: Application
    Filed: August 14, 2012
    Publication date: December 27, 2012
    Applicants: THE UNIVERSITY OF WASHINGTON, Vical Incorporated
    Inventors: Adrian VILALTA, Michal Maragalith, Lichun Dong, David M. Koelle